JPS5946269A - インデノ〔１，２―ｂ〕ピロ−ル誘導体 - Google Patents

インデノ〔１，２―ｂ〕ピロ−ル誘導体

Info

Publication number
JPS5946269A
JPS5946269A JP57156997A JP15699782A JPS5946269A JP S5946269 A JPS5946269 A JP S5946269A JP 57156997 A JP57156997 A JP 57156997A JP 15699782 A JP15699782 A JP 15699782A JP S5946269 A JPS5946269 A JP S5946269A
Authority
JP
Japan
Prior art keywords
formula
action
compound
halogen
compound shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57156997A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6250464B2 (https=
Inventor
Tetsuji Tawara
田原　哲治
Masafumi Arita
有田　雅文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Priority to JP57156997A priority Critical patent/JPS5946269A/ja
Priority to EP83902820A priority patent/EP0118566B1/en
Priority to PCT/JP1983/000287 priority patent/WO1984000962A1/ja
Priority to DE8383902820T priority patent/DE3369982D1/de
Priority to US06/609,355 priority patent/US4578397A/en
Publication of JPS5946269A publication Critical patent/JPS5946269A/ja
Publication of JPS6250464B2 publication Critical patent/JPS6250464B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP57156997A 1982-09-08 1982-09-08 インデノ〔１，２―ｂ〕ピロ−ル誘導体 Granted JPS5946269A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP57156997A JPS5946269A (ja) 1982-09-08 1982-09-08 インデノ〔１，２―ｂ〕ピロ−ル誘導体
EP83902820A EP0118566B1 (en) 1982-09-08 1983-08-30 INDENO[1,2-b]PYRROLE DERIVATIVES
PCT/JP1983/000287 WO1984000962A1 (fr) 1982-09-08 1983-08-30 DERIVES D'INDENO AD1,2-b BD PYRROLE
DE8383902820T DE3369982D1 (de) 1982-09-08 1983-08-30 Indenoû1,2-b¨pyrrole derivatives
US06/609,355 US4578397A (en) 1982-09-08 1983-08-30 Indeno(1,2-b)pyrrole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57156997A JPS5946269A (ja) 1982-09-08 1982-09-08 インデノ〔１，２―ｂ〕ピロ−ル誘導体

Publications (2)

Publication Number Publication Date
JPS5946269A true JPS5946269A (ja) 1984-03-15
JPS6250464B2 JPS6250464B2 (https=) 1987-10-24

Family

ID=15639921

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57156997A Granted JPS5946269A (ja) 1982-09-08 1982-09-08 インデノ〔１，２―ｂ〕ピロ−ル誘導体

Country Status (5)

Country Link
US (1) US4578397A (https=)
EP (1) EP0118566B1 (https=)
JP (1) JPS5946269A (https=)
DE (1) DE3369982D1 (https=)
WO (1) WO1984000962A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2524422T3 (es) 2010-12-14 2014-12-09 Syngenta Participations Ag Derivados de estrigolactamas y su uso como reguladores del crecimiento vegetal
GB201121803D0 (en) 2011-12-16 2012-02-01 Syngenta Participations Ag Plant growth regulating compounds
JP7505934B2 (ja) * 2020-07-28 2024-06-25 東芝テック株式会社 無線タグ読取装置

Also Published As

Publication number Publication date
EP0118566A1 (en) 1984-09-19
US4578397A (en) 1986-03-25
EP0118566B1 (en) 1987-03-04
JPS6250464B2 (https=) 1987-10-24
DE3369982D1 (de) 1987-04-09
EP0118566A4 (en) 1985-03-06
WO1984000962A1 (fr) 1984-03-15

Similar Documents

Publication Publication Date Title
EP0561941B1 (en) N-substituted lactams useful as cholecystokinin antagonists
US4215123A (en) Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
TW201124378A (en) Indole compounds and pharmaceutical use thereof
DE19638020A1 (de) Die gastrointestinale Durchblutung fördernde Arzneimittel
NO874834L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridinoner.
TW200845981A (en) Compounds and compositions as channel activating protease inhibitors
NZ202071A (en) Omega-(1-(benzoxa(thia)zol-2-yl or indol-2-yl)hydrazino)alkanenitriles
PT1369419E (pt) Composto de n-fenilarilsulfonamida, fármaco contendo o composto como ingrediente activo, produtos intermédios para a produção do composto e processos para a produção do composto
US3703542A (en) Hydroxamic acid derivatives of 1-amino-cyclohexanecarboxylic acid
EP0130141B1 (de) Neue beta-Carboline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel (H)
JPS5946269A (ja) インデノ〔１，２―ｂ〕ピロ−ル誘導体
US4424226A (en) Pyridobenzodiazepinones, pharmaceutical compositions thereof and method of use thereof
Fanta et al. The Condensation of Sodium Nitromalonaldehyde with Cyanoacetamide1
SU1025328A3 (ru) Способ получени 5-метил-10,11-дигидро-5 @ -дибензо( @ , @ )циклогептен-5,10-имина
US3839433A (en) Adamantylcarboxamidophenylalkanoic acids and esters thereof
JPS60500765A (ja) 置換された１−アザスピロ〔４．５〕デカンおよび１−アザスピロ〔５．５〕ウンデカン
EP1366045A2 (en) Efficient process for the preparation of a factor xa inhibitor
TW202504605A (zh) 螺環烯基類或氮雜烯基類化合物及其藥物組合物、製備方法和用途
JPS5951282A (ja) イミノピロリジニルインド−ルの製法
Shaw et al. Analogs of Aspergillic Acid. III. Synthesis of Cyclic Hydroxamic Acids with a Five-membered Ring
JPS59205372A (ja) 縮合７員環化合物およびそれを含有してなる高血圧症予防・治療剤
US3553241A (en) Azacycloalkylferrocene
EP0011282B1 (de) Thienylbenzoesäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate auf Basis dieser Verbindungen
JPH03167189A (ja) 芳香族酸のｎ―アザビシクロ〔３．３．０〕オクタンアミド
DE1793730A1 (de) Zwischenprodukt zur herstellung von phosphorylkreatinin und phosphorylkreatin